NEWS & MEDIA
 
SUPERCHARGING FLU VACCINE FOR VULNERABLE AUSTRALIANS

Clinical trial to test benefits of fibre supplement to enhance flu vaccine

> Read More
NEWS & MEDIA
 
VACCINE PATCH TRIAL SUCCESS

Vaxxas’ micro-needle patch demonstrated significantly enhanced immune response compared to vaccination by needle/syringe.

> Read More
NEWS & MEDIA
 
PARKINSON’S DISEASE LINKED TO GENE TARGETED BY BLUE-GREEN ALGAE TOXIN

Scientists have discovered a possible link between Parkinson’s disease and a gene impacted by a neurotoxin found in blue-green algae.

> Read More
NEWS & MEDIA
 
NEW BIOBANK IMPROVES BREAST CANCER RESEARCH


> Read More
NEWS & MEDIA
 
NEW DRUG COMBINATION COULD SUPPORT BETTER CANCER TREATMENTS

Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them.

> Read More
NEWS & MEDIA
 
MELANOMA RISK IN YOUNG AUSTRALIANS GOES BEYOND THE BURN


> Read More
NEWS & MEDIA
 
TRI CEO CALLS FOR EUREKA AWARD NOMINATIONS

Applications for the 2020 Australian Museum Eureka Prizes open this Wednesday!

> Read More
NEWS & MEDIA
 
MULTIMILLION DOLLAR INVESTMENT IN NEW THROAT CANCER TREATMENT

World-first human trial into throat cancer associated with Human Papillomavirus using a completely new treatment approach

> Read More
NEWS & MEDIA
 
SOURCE OF INFLAMMATION FOUND FOR RHEUMATOID ARTHRITIS

Researchers find new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.

> Read More
NEWS & MEDIA
 
1.5 MILLION FUNDING FOR AGEING AND AGED CARE RESEARCH

The Australian Government awarded $1.5 million funding to Prof Ruth Hubbard for ageing and aged care research

> Read More
NEWS & MEDIA
 
PROFESSOR RUTH HUBBARD RECEIVES $1.5 MILLION IN RESEARCH FUNDING

Prof Hubbard from UQ Faculty of Medicine and her team who will be leading this project right here at TRI.

> Read More
NEWS & MEDIA
 
SPARQ-ED IS BACK

SPARQ-ed is seeking expressions of interest from researchers in the building who would like to inspire students to consider STEM subjects and careers

> Read More
NEWS & MEDIA
 
NEW CEO FOR THE TRANSLATIONAL RESEARCH INSTITUTE

The Translational Research Institute (TRI) Board has appointed renowned respiratory specialist, Professor Scott Bell as the Institute’s new CEO.

> Read More
NEWS & MEDIA
 
CANCER CHROMOSOMES GIVE THE GAME AWAY


> Read More
NEWS & MEDIA
 
2019 EVENTS WRAP UP

Take a look at a snapshot of the events held at TRI through out 2019.

> Read More
NEWS & MEDIA
 
BLOOD PRESSURE DRUG COULD HELP PROBLEM DRINKERS

The drug, pindolol, could be beneficial in treating alcohol use disorders.

> Read More
NEWS & MEDIA
 
TARGETING OBESITY-RELATED LIVER DISEASE

A new treatment for obesity-related liver diseases is being developed by a new UQ spin-off company.

> Read More
NEWS & MEDIA
 
NEW CEO FOR THE TRANSLATIONAL RESEARCH INSTITUTE


> Read More
NEWS & MEDIA
 
IMMUNE ‘CHECKPOINT SWITCH-OFF’ ENABLES DESTRUCTION OF CANCER CELLS

Researchers have discovered a new mechanism used by Epstein-Barr virus, which can cause blood cancers, to evade the immune system.

> Read More
NEWS & MEDIA
 
METRO SOUTH HEALTH REWARD, RECOGNITION AND RESEARCH EXCELLENCE AWARDS (RRREA)

Almost 50 awards were presented on the evening totalling over $3 million in additional funding

> Read More
NEWS & MEDIA
 
2020 ROOM BOOKINGS CALENDAR

The TRI 2020 room booking calendar will open at 10am on Monday the 18th of November 2019.

> Read More
NEWS & MEDIA
 
DR FELICITY DAVIS WINS 2019 METCALF PRIZES FOR STEM CELL RESEARCH

Winners of the National Stem Cell Foundation of Australia’s Metcalf Prizes announced

> Read More
NEWS & MEDIA
 
AUSTRALIAN CENTRE FOR COMPLEX INTEGRATED SURGICAL SOLUTIONS (ACCISS) LAUNCH

ACCISS offers hope that difficult clinical problems can be solved.

> Read More
NEWS & MEDIA
 
HEALTH ALERT OVER EIGHT NEW MEASLES CASES REPORTED IN BRISBANE

Eight new cases of measles were reported in Brisbane’s southside area including the PA Hospital

> Read More